[1] Hsiao K, Chapman P, Nilsen S, et al.Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice[J]. Science, 1996, 274(5284):99-102. [2] Silver L.Encyclopedia of Genetics [M]. New York: Academic Press: 2001:680. [3] Bilkei-Gorzo A.Genetic mouse models of brain ageing and Alzheimer’s disease[J]. Pharmacol Ther, 2014, 142(2):244-257. [4] 李国营, 张革, 胡金家,等. APPSWE转基因鼠的繁育及子代鉴定的研究[J]. 中国病理生理杂志, 2004(1):114-117. [5] Lassalle JM, Halley H, Daumas S, et al.Effects of the genetic background on cognitive performances of TG2576 mice[J]. Behav Brain Res, 2008, 191(1):104-110. [6] Alexander G, Hanna A, Serna V, et al.Increased aggression in males in transgenic Tg2576 mouse model of Alzheimer’s disease[J]. Behav Brain Res, 2011, 216(1):77-83. [7] 李国营, 汪华侨, 胡金家, 等. AD转基因模型Tg2576鼠阳性子鼠的病理和认知行为变化[J]. 神经解剖学杂志, 2006(4):384-388. [8] Frautschy SA, Yang F, Irrizarry M, et al.Microglial response to amyloid plaques in APPsw transgenic mice[J]. Am J Pathol, 1998, 152(1):307-317. [9] Dong H, Csernansky CA, Martin MV, et al.Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer’s disease[J]. Psychopharmacology (Berl), 2005, 181(1):145-152. [10] Unger C, Svedberg MM, Yu WF, et al.Effect of subchronic treatment of memantine, galantamine, and nicotine in the brain of Tg2576 (APPswe) transgenic mice[J]. J Pharmacol Exp Ther, 2006, 317(1):30-36. |